Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cureos is a French medical technology company that specializes in the design, development, and manufacture of synthetic bone substitutes for use in orthopedic, dental, and spinal surgery. The company leverages its expertise in bioceramics to create osteoconductive materials that facilitate bone regeneration and repair. Its flagship product line, C-Graft, consists of calcium phosphate-based granules and putties designed to fill bone voids and support structural integrity during the healing process. Cureos focuses on providing high-quality, biocompatible solutions that serve as alternatives to autografts and allografts. The company's products are CE-marked and distributed internationally to meet the needs of surgeons in various clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CUREOS.